Mental Training for Adults With Mild Cognitive Impairment
1 other identifier
interventional
22
1 country
1
Brief Summary
This study aims to determine the feasibility and acceptability of conducting a larger randomized clinical trial to test whether individuals with MCI can benefit from mental training programs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2019
CompletedFirst Posted
Study publicly available on registry
March 29, 2019
CompletedStudy Start
First participant enrolled
April 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedSeptember 15, 2022
September 1, 2022
12 months
March 26, 2019
September 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Recruitment feasibility
Number of subjects recruited within 6 months; determine the number of people excluded for each inclusion/exclusion criterion; assessing reasons why eligible people decide not to enroll.
6 months
Retention
Remaining in the study for the full duration of all testing time points (yes/no). Quantify the reasons for dropout
6 months
Adherence to study protocol
Number of classes attended; number of times the subject practiced prescribed activities at home; number of people who complete each test/assessment.
6 months
Study Arms (2)
Mindfulness
EXPERIMENTALClass meeting three times a week for six months, led by a certified mindfulness meditation instructor. Includes instruction and practice on techniques such as breathing, body scan, physical sensations, and yoga.
Brain Games and Puzzles
ACTIVE COMPARATORClass meeting three times a week for six months, led by a qualified instructor. Includes teaching and practice of puzzles such as word searches, crossword puzzles, Sudoku, and KenKen.
Interventions
Mindfulness meditation is a technique of sustained attention and focus, involving preventing the mind from wandering from the meditative object (i.e. breath or body sensations)
Intervention will include the instruction and practice of puzzles such as word searches, crossword puzzles, Sudoku, and KenKen.
Eligibility Criteria
You may qualify if:
- CDR (clinical dementia rating) of 0.5
- years of age
- Able to speak, read, and understand English
- Willing to participate in a 6 month study and undergo 2 MRI scans at Mass General Hospital
- A score suggesting Mild Cognitive Impairment on the Telephone Interview for Cognitive Status (TICS)
- A Mini Mental State Exam adjusted for age and education of 24 to 30
- Stable medications for at least 30 days
- Subjects with well-controlled vascular risk factors such as treated hypertension, treated hyperlipidemia or well-controlled Type II diabetes (glucose levels \< 250) will be included.
- Subjects with a history of cerebrovascular problems but have no persistent neurological deficits will be included
- Available for scheduled class times for both study courses
- Able to complete 40 minutes of homework per day during the 6-month course
- CDR (clinical dementia rating) of 0.5
You may not qualify if:
- CDR score other than 0.5
- Cardiovascular disease, stroke, congestive heart failure
- Has surgical aneurysm clips, neurostimulator, implanted pumps, metal fragments in eyes, cardiac pacemaker, non-removable nitroglycerin patch, non-MRI compatible cochlear implants, any other non-MRI compatible metal in body
- Has permanent bridgework in upper mouth that could interfere with MRI scan
- Active hematological, renal, pulmonary, endocrine, or hepatic disorders
- Uncontrolled high blood pressure
- Uncontrolled diabetes or insulin-treated diabetes (diabetes that is controlled with no more than one oral medication will be allowed)
- A history of neurological disease or injury, including a history of seizures or significant head trauma (i.e. extended loss of consciousness, bleeding in the brain, Parkinson's disease, stroke)
- Received treatment for cancer within the last year (skin cancer will be allowed as will any cancer more than 2 years since the last treatment)
- Diagnosis of schizophrenia, PTSD, bipolar disorder, or psychotic disorder at any point during lifetime
- Any axis I psychiatric disorder within the last 12 months
- Weighs more than 350 pounds
- Neurological or medical conditions that would interfere with study procedures or confound results, such as conditions that alter cerebral blood flow or metabolism
- Unstable medications or on medications with CNS effects including cholinesterase inhibitors, memantine, and antidepressants
- Use of psychotropic medications within 12 months prior to the study
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02119, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sara Lazar, PhD
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Investigator and outcomes assessors will be masked to the group assignment of participants (mindfulness or brain games and puzzles).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Research Scientist
Study Record Dates
First Submitted
March 26, 2019
First Posted
March 29, 2019
Study Start
April 10, 2019
Primary Completion
March 30, 2020
Study Completion
December 31, 2021
Last Updated
September 15, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share